![Scott Kellen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Kellen
Director of Finance/CFO at
DIAMEDICA THERAPEUTICS INC.
Net worth: 399 054 $ as of 2026-05-30
Profile
Scott Kellen currently works at DiaMedica Therapeutics, Inc., as Chief Financial Officer & Secretary from 2018.
Mr. Kellen also formerly worked at Transoma Medical, Inc., as Finance Director from 2007 to 2009, ev3, Inc., as Controller from 2005 to 2007, Kips Bay Medical, Inc., as COO, CFO, Secretary, VP & Head-Investor Relations from 2012 to 2015, Sun Biopharma, Inc., as Chief Financial Officer & Vice President, Deloitte & Touche LLP, as Senior Audit Manager from 2003 to 2005, and Panbela Therapeutics, Inc., as Chief Financial Officer, Secretary, CAO & VP from 2015 to 2018.
Mr. Kellen received his undergraduate degree from the University of South Dakota.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-31 | 34,330 ( 0.06% ) | 205 637 $ | 2026-05-30 | |
| 2026-05-31 | 32,290 ( -.--% ) | 193 417 $ | 2026-05-30 |
Scott Kellen active positions
| Companies | Position | Start |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Director of Finance/CFO | 2018-03-31 |
Former positions of Scott Kellen
| Companies | Position | End |
|---|---|---|
| SUN BIOPHARMA INC | Director of Finance/CFO | 2018-03-31 |
Transoma Medical, Inc.
 Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Manufactures and distributes implantable, wireless diagnostic and monitoring systems | Director of Finance/CFO | 2009-04-30 |
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and distributes medical devices | Comptroller/Controller/Auditor | 2007-09-30 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Comptroller/Controller/Auditor | 2005-03-31 |
Sun Biopharma, Inc. /Old/
 Sun Biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Director of Finance/CFO | - |
Training of Scott Kellen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
99
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and distributes medical devices | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Kips Bay Medical, Inc.
 Kips Bay Medical, Inc. Medical SpecialtiesHealth Technology Engages in the development, manufacturing and commercialization of proprietary external saphenous vein support technology | Health Technology |
Sun Biopharma, Inc. /Old/
Sun Biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of South Dakota
 University of South Dakota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transoma Medical, Inc.
Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Manufactures and distributes implantable, wireless diagnostic and monitoring systems | Health Services |
Panbela Therapeutics, Inc.
 Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
- Stock Market
- Insiders
- Scott Kellen
